Title : Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.

Pub. Date : 2013 Apr

PMID : 22773548






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cell line studies showed that metformin inhibits hepatocyte proliferation and induces cell cycle arrest at G0/G1 phase via AMP-activated protein kinase and its upstream kinase LKB1 to upregulate p21/Cip1 and p27/Kip1 and downregulate cyclin D1 in a dose-dependent manner, but independent of p53. Metformin interferon alpha inducible protein 27 Homo sapiens